Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Oligoprogressive Lung Non-Small Cell Carcinoma”

22 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 22 results

Early research (Phase 1)Looking for participantsNCT03546829
What this trial is testing

Safety Trial of Antimicrobial Therapy and Precision Radiation Therapy in Patients With Oligoprogressive Non-small Cell Lung Cancer

Who this might be right for
Early Stage Non-Small Cell Lung Cancer
Abramson Cancer Center at Penn Medicine 10
Early research (Phase 1)Not Yet RecruitingNCT07619599
What this trial is testing

A PET Imaging Agent (64Cu-DOTA-Pembrolizumab) for Determining Treatment Response Among Patients With Stage IV Non-small Cell Lung Cancer Receiving Pembrolizumab

Who this might be right for
Metastatic Lung Non-Small Cell CarcinomaMetastatic Malignant Neoplasm in the BrainOligoprogressive Lung Non-Small Cell Carcinoma+1 more
City of Hope Medical Center 6
Large-scale testing (Phase 3)Looking for participantsNCT06523673
What this trial is testing

Stereotactic Body Radiotherapy for Oligo-Progression Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Metastatic Non-Small Cell Lung CancerNSCLC Stage IVOligoProgressive Metastatic Disease
Second Affiliated Hospital, School of Medicine, Zhejiang University 104
Testing effectiveness (Phase 2)Active Not RecruitingNCT05089916
What this trial is testing

Radiation During Osimertinib Treatment: a Safety and Efficacy Cohort Study

Who this might be right for
NSCLCEGFR Positive Non-small Cell Lung CancerOligoprogression
AIO-Studien-gGmbH 42
Testing effectiveness (Phase 2)UnknownNCT04970693
What this trial is testing

Furmonertinib Combined With Radiotherapy for Non-small Cell Lung Cancer With Oligoprogression

Who this might be right for
Non-small Cell Lung CancerOligoprogressive
Sun Yat-sen University 64
Not applicableLooking for participantsNCT06103682
What this trial is testing

LOcally ABLatIve ThErapy for OligopRogressive Lung And Thoracic MalignanciEs (OBLITERATE)

Who this might be right for
Non-small Cell Lung CancerOligoprogressiveSmall-cell Lung Cancer
University of California, Davis 100
Testing effectiveness (Phase 2)WithdrawnNCT06331585
What this trial is testing

Effect of Low-dose Radiotherapy on Tumor Immune Microenvironment in Oligometastases of NSCLC After Immunotherapy

Who this might be right for
Low-dose RadiotherapyTumor MicroenvironmentNon-Small Cell Lung Cancer
Hetian District People's Hospital
Large-scale testing (Phase 3)Active Not RecruitingNCT07076693
What this trial is testing

Standard-of-care Systemic Therapy With or Without Local Therapy in Patients With Oligoprogressive Non-Small Cell Lung Cancer(NSCLC）

Who this might be right for
OligoProgressive Metastatic DiseaseNon-Small Cell Lung Cancer
Shanghai Chest Hospital 97
Testing effectiveness (Phase 2)Active Not RecruitingNCT03808662
What this trial is testing

Randomized Study of Stereotactic Body Radiation Therapy (SBRT) in Patients With Oligoprogressive Metastatic Cancers of the Breast and Lung

Who this might be right for
TNBC - Triple-Negative Breast CancerTriple Negative Breast CancerNSCLC+4 more
Memorial Sloan Kettering Cancer Center 107
Testing effectiveness (Phase 2)UnknownNCT05387044
What this trial is testing

SBRT for Oligoprogressive NSCLC After First Line Treatment With Immune Checkpoint Inhibitors

Who this might be right for
NSCLC Stage IV
Zhejiang Cancer Hospital 28
Testing effectiveness (Phase 2)Looking for participantsNCT06014827
What this trial is testing

Biologically Guided Radiation Therapy (BgRT) and Stereotactic Body Radiation Therapy (SBRT) to Tyrosine Kinase Inhibitor in Oligoprogressive Oncogenic Positive Non-Small Cell Lung Carcinoma

Who this might be right for
Lung Non-Small Cell CarcinomaStage IV Lung Cancer AJCC v8
City of Hope Medical Center 32
Testing effectiveness (Phase 2)Looking for participantsNCT07193641
What this trial is testing

A Study on Using SFRT With Standard Treatment for Oligoprogressive NSCLC

Who this might be right for
Non Small Cell Lung Cancer
Second Affiliated Hospital, School of Medicine, Zhejiang University 25
Testing effectiveness (Phase 2)Looking for participantsNCT05830058
What this trial is testing

Positron Emission Tomography (PET) Guided Stereotactic Body Radiation Therapy for the Treatment of Oligoprogressive Non-small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma

Who this might be right for
Lung Non-Small Cell CarcinomaMalignant Solid NeoplasmMelanoma+1 more
City of Hope Medical Center 32
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06813664
What this trial is testing

CtDNA-Guided CURB for OPD mNSCLC on TKI (CURB-TKI)

Who this might be right for
Metastatic NSCLC - Non-Small Cell Lung CancerOligoProgressive Metastatic Disease
University Health Network, Toronto 60
Testing effectiveness (Phase 2)Looking for participantsNCT04892953
What this trial is testing

Local Consolidative Therapy and Durvalumab for Oligoprogressive and Polyprogressive Stage III NSCLC After Chemoradiation and Anti-PD-L1 Therapy

Who this might be right for
Stage III Lung Cancer AJCC v8Stage III Lung Non-Small Cell Cancer AJCC v7Stage IIIA Lung Cancer AJCC v8+4 more
M.D. Anderson Cancer Center 51
Large-scale testing (Phase 3)Looking for participantsNCT06686771
What this trial is testing

Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Canadian Cancer Trials Group 320
Not applicableLooking for participantsNCT04216121
What this trial is testing

LAT for Oligoprogressive NSCLC Treated With First-line OSImertinib

Who this might be right for
Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor
Universitaire Ziekenhuizen KU Leuven 39
Testing effectiveness (Phase 2)Study completedNCT02759835
What this trial is testing

Local Ablative Therapy for Treatment of Oligoprogressive, EGFR-Mutated, Non-Small Cell Lung Cancer After Treatment With Osimertinib

Who this might be right for
Lung AdenocarcinomaLung Neoplasms
National Cancer Institute (NCI) 37
Testing effectiveness (Phase 2)Looking for participantsNCT04405401
What this trial is testing

Stereotactic Ablative Radiotherapy for Oligo-Progressive Non Small Cell Lung Cancer

Who this might be right for
Lung Cancer Metastatic
Centre hospitalier de l'Université de Montréal (CHUM) 68
Testing effectiveness (Phase 2)Ended earlyNCT04549428
What this trial is testing

Atezolizumab Plus 8 Gy Single-fraction Radiotherapy for Advanced Oligoprogressive NSCLC

Who this might be right for
NSCLC Stage IV
Oncology Institute of Southern Switzerland 12
Load More Results